Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled... von Fizazi, Karim, Prof Dr, Scher, Howard I, Prof, Molina, Arturo, MD, Logothetis, Christopher J, Prof, Chi, Kim N, MD, Jones, Robert J, PhD, Staffurth, John N, MD, North, Scott, MD, Vogelzang, Nicholas J, MD, Saad, Fred, Prof, Mainwaring, Paul, MD, Harland, Stephen, MD, Goodman, Oscar B, MD, Sternberg, Cora N, MD, Li, Jin Hui, PhD, Kheoh, Thian, PhD, Haqq, Christopher M, MD, de Bono, Johann S, Prof

Volltext

Abiraterone and Increased Survival in Metastatic Prostate Cancer von de Bono, Johann S, Logothetis, Christopher J, Molina, Arturo, Fizazi, Karim, North, Scott, Chu, Luis, Chi, Kim N, Jones, Robert J, Goodman, Oscar B, Saad, Fred, Staffurth, John N, Mainwaring, Paul, Harland, Stephen, Flaig, Thomas W, Hutson, Thomas E, Cheng, Tina, Patterson, Helen, Hainsworth, John D, Ryan, Charles J, Sternberg, Cora N, Ellard, Susan L, Fléchon, Aude, Saleh, Mansoor, Scholz, Mark, Efstathiou, Eleni, Zivi, Andrea, Bianchini, Diletta, Loriot, Yohann, Chieffo, Nicole, Kheoh, Thian, Haqq, Christopher M, Scher, Howard I

Volltext

The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer von Turnham, Daniel J., Bullock, Nicholas, Dass, Manisha S., Staffurth, John N., Pearson, Helen B.

Volltext

SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus von Hurt, Christopher N, Nixon, Lisette S, Griffiths, Gareth O, Al-Mokhtar, Ruby, Gollins, Simon, Staffurth, John N, Phillips, Ceri J, Blazeby, Jane M, Crosby, Tom D

Volltext

Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant Prostate Cancer von Turnham, Daniel J, Mullen, Manisha S, Bullock, Nicholas P, Gilroy, Kathryn L, Richards, Anna E, Patel, Radhika, Quintela, Marcos, Meniel, Valerie S, Seaton, Gillian, Kynaston, Howard, Clarkson, Richard W E, Phesse, Toby J, Nelson, Peter S, Haffner, Michael C, Staffurth, John N, Pearson, Helen B

Volltext

Certification in reporting multiparametric magnetic resonance imaging of the prostate: recommendations of a UK consensus meeting von Barrett, Tristan, Padhani, Anwar R., Patel, Amit, Ahmed, Hashim U., Allen, Clare, Bardgett, Harry, Belfield, Jane, Brizmohun Appayya, Mrishta, Harding, Thomas, Hoch, Ornella‐Shanin, Keanie, Julian Y., Liyanage, Sidath H., Papoutsaki, Marianthi‐Vasiliki, Punwani, Shonit, Robinson, Mark J.C., Rajesh, Arumugam, Stafurth, John N., Meulen, Jan, Richenberg, Jonathan

Volltext

Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016) von Staffurth, John N., Haviland, Joanne S., Wilkins, Anna, Syndikus, Isabel, Khoo, Vincent, Bloomfield, David, Parker, Chris, Logue, John, Scrase, Christopher, Birtle, Alison, Malik, Zafar, Panades, Miguel, Eswar, Chinnamani, Graham, John, Russell, Martin, Ferguson, Catherine, O’Sullivan, Joe M., Cruickshank, Clare A., Dearnaley, David, Hall, Emma

Volltext

Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effective... von Woods, Beth S., Sideris, Eleftherios, Sydes, Matthew R., Gannon, Melissa R., Parmar, Mahesh K.B., Alzouebi, Mymoona, Attard, Gerhardt, Birtle, Alison J., Brock, Susannah, Cathomas, Richard, Chakraborti, Prabir R., Cook, Audrey, Cross, William R., Dearnaley, David P., Gale, Joanna, Gibbs, Stephanie, Graham, John D., Hughes, Robert, Jones, Rob J., Laing, Robert, Mason, Malcolm D., Matheson, David, McLaren, Duncan B., Millman, Robin, O'Sullivan, Joe M., Parikh, Omi, Parker, Christopher C., Peedell, Clive, Protheroe, Andrew, Ritchie, Alastair W.S., Robinson, Angus, Russell, J. Martin, Simms, Matthew S., Srihari, Narayanan N., Srinivasan, Rajaguru, Staffurth, John N., Sundar, Santhanam, Thalmann, George N., Tolan, Shaun, Tran, Anna T.H., Tsang, David, Wagstaff, John, James, Nicholas D., Sculpher, Mark J.

Volltext

2899: Can perfusion predict response to treatment in patients undergoing stereotactic radiosurgery? von Iqbal, Najmus S., Wise, Richard, Williams, Maeve, Staffurth, John N., Powell, James R.

Volltext

1145: Hippocampal Dosimetry and Neurocognitive Function in Patients undergoing Stereotactic Radiosurgery von Iqbal, Najmus S., Smalley, Michelle, Daisley-Devoy, Tara, Williams, Maeve, Staffurth, John N., Maclean, Jillian, Powell, James R.

Volltext

Clinical implementation of dynamic and step-and-shoot IMRT to treat prostate cancer with high risk of pelvic lymph node involvement von Adams, Elizabeth J, Convery, David J, Cosgrove, Vivian P, McNair, Helen A, Staffurth, John N, Vaarkamp, Jaap, Nutting, Christopher M, Warrington, Alan P, Webb, Steve, Balyckyi, Jan, Dearnaley, David P

Volltext

Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effective... von Woods, Beth S, Sideris, Eleftherios, Sydes, Matthew R, Gannon, Melissa R, Parmar, Mahesh KB, Alzouebi, Mymoona, Attard, Gerhardt, Birtle, Alison J, Brock, Susannah, Cathomas, Richard, Chakraborti, Prabir R, Cook, Audrey, Cross, William R, Dearnaley, David P, Gale, Joanna, Gibbs, Stephanie, Graham, John D, Hughes, Robert, Jones, Rob J, Laing, Robert, Mason, Malcolm D, Matheson, David, McLaren, Duncan B, Millman, Robin, O'Sullivan, Joe M, Parikh, Omi, Parker, Christopher C, Peedell, Clive, Protheroe, Andrew, Ritchie, Alastair WS, Robinson, Angus, Russell, J Martin, Simms, Matthew S, Srihari, Narayanan N, Srinivasan, Rajaguru, Staffurth, John N, Sundar, Santhanam, Thalmann, George N, Tolan, Shaun, Tran, Anna TH, Tsang, David, Wagstaff, John, James, Nicholas D, Sculpher, Mark J

Volltext

Abiraterone and increased survival in metastatic prostate cancer von de Bono, Johann S, Logothetis, Christopher J, Molina, Arturo, Fizazi, Karim, North, Scott, Chu, Luis, Chi, Kim N, Jones, Robert J, Goodman, Oscar B, Saad, Fred, Staffurth, John N, Mainwaring, Paul, Harland, Stephen, Flaig, Thomas W, Hutson, Thomas E, Cheng, Tina, Patterson, Helen, Hainsworth, John D, Ryan, Charles J, Sternberg, Cora N, Ellard, Susan L, Fléchon, Aude, Saleh, Mansoor, Scholz, Mark, Efstathiou, Eleni, Zivi, Andrea, Bianchini, Diletta, Loriot, Yohann, Chieffo, Nicole, Kheoh, Thian, Haqq, Christopher M, Scher, Howard I, COU-AA-301 Investigators, [missing], Rottey, Sylvie

Volltext

Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE):Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiven... von Woods, Beth S, Sideris, Eleftherios, Sydes, Matthew R, Gannon, Melissa R, Parmar, Mahesh K.B, Alzouebi, Mymoona, Attard, Gerhardt, Birtle, Alison J, Brock, Susannah, Cathomas, Richard, Chakraborti, Prabir R, Cook, Audrey, Cross, William R, Dearnaley, David P, Gale, Joanna, Gibbs, Stephanie, Graham, John D, Hughes, Robert, Jones, Rob J, Laing, Robert, Mason, Malcolm D, Matheson, David, McLaren, Duncan B, Millman, Robin, O'Sullivan, Joe M, Parikh, Omi, Parker, Christopher C, Peedell, Clive, Protheroe, Andrew, Ritchie, Alastair W.S, Robinson, Angus, Russell, J. Martin, Simms, Matthew S, Srihari, Narayanan N, Srinivasan, Rajaguru, Staffurth, John N, Sundar, Santhanam, Thalmann, George N, Tolan, Shaun, Tran, Anna T.H, Tsang, David, Wagstaff, John, James, Nicholas D, Sculpher, Mark J

Volltext bestellen

Rucaparib or Physician’s Choice in Metastatic Prostate Cancer von Fizazi, Karim, Piulats, Josep M., Reaume, M. Neil, Ostler, Peter, McDermott, Ray, Gingerich, Joel R., Pintus, Elias, Sridhar, Srikala S., Bambury, Richard M., Emmenegger, Urban, Lindberg, Henriette, Morris, David, Nolè, Franco, Staffurth, John, Redfern, Charles, Sáez, María I., Abida, Wassim, Daugaard, Gedske, Heidenreich, Axel, Krieger, Laurence, Sautois, Brieuc, Loehr, Andrea, Despain, Darrin, Heyes, Catherine A., Watkins, Simon P., Chowdhury, Simon, Ryan, Charles J., Bryce, Alan H.

Volltext

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer von Hamdy, Freddie C., Donovan, Jenny L., Lane, J. Athene, Metcalfe, Chris, Davis, Michael, Turner, Emma L., Martin, Richard M., Young, Grace J., Walsh, Eleanor I., Bryant, Richard J., Bollina, Prasad, Doble, Andrew, Doherty, Alan, Gillatt, David, Gnanapragasam, Vincent, Hughes, Owen, Kockelbergh, Roger, Kynaston, Howard, Paul, Alan, Paez, Edgar, Powell, Philip, Rosario, Derek J., Rowe, Edward, Mason, Malcolm, Catto, James W.F., Peters, Tim J., Oxley, Jon, Williams, Naomi J., Staffurth, John, Neal, David E.

Volltext

Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial von Crosby, Thomas, FRCR, Hurt, Christopher N, MSc, Falk, Stephen, MD, Gollins, Simon, FRCR, Mukherjee, Somnath, FRCP, Staffurth, John, MD, Ray, Ruby, PhD, Bashir, Nadim, BSc, Bridgewater, John A, FRCP, Geh, J Ian, FRCP, Cunningham, David, Prof, Blazeby, Jane, Prof, Roy, Rajarshi, FRCR, Maughan, Tim, Prof, Griffiths, Gareth, MSc

Volltext

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial von Mukherjee, Somnath, Dr, Hurt, Christopher N, MSc, Bridgewater, John, MD, Falk, Stephen, MD, Cummins, Sebastian, MRCP, Wasan, Harpreet, FRCR, Crosby, Tom, FRCR, Jephcott, Catherine, FRCR, Roy, Rajarshi, FRCR, Radhakrishna, Ganesh, FRCR, McDonald, Alec, MD, Ray, Ruby, PhD, Joseph, George, MBBS, Staffurth, John, MD, Abrams, Ross A, Prof, Griffiths, Gareth, MSc, Maughan, Tim, Prof

Volltext

Health-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic Cancer von Hurt, Christopher N., MSc, Mukherjee, Somnath, FRCP, Bridgewater, John, MD, Falk, Stephen, MD, Crosby, Tom, FRCR, McDonald, Alec, MD, Joseph, George, MBBS, Staffurth, John, MD, Abrams, Ross A., MD, Blazeby, Jane M., MD, Bridges, Sarah, BSc, Dutton, Peter, MSc, Griffiths, Gareth, PhD, Maughan, Tim, FRCR, Johnson, Colin, MChir, FRCS

Volltext

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-la... von Brand, Douglas H, Tree, Alison C, Ostler, Peter, van der Voet, Hans, Loblaw, Andrew, Chu, William, Ford, Daniel, Tolan, Shaun, Jain, Suneil, Martin, Alexander, Staffurth, John, Camilleri, Philip, Kancherla, Kiran, Frew, John, Chan, Andrew, Dayes, Ian S, Henderson, Daniel, Brown, Stephanie, Cruickshank, Clare, Burnett, Stephanie, Duffton, Aileen, Griffin, Clare, Hinder, Victoria, Morrison, Kirsty, Naismith, Olivia, Hall, Emma, van As, Nicholas, Dodds, D, Lartigau, E, Patton, S, Thompson, A, Winkler, M, Wells, P, Lymberiou, T, Saunders, D, Vilarino-Varela, M, Vavassis, P, Tsakiridis, T, Carlson, R, Rodrigues, G, Tanguay, J, Iqbal, S, Morgan, S, Mihai, A, Li, A, Din, O, Panades, M, Wade, R, Rimmer, Y, Armstrong, J, Oommen, N

Volltext